AKARI THERAPEUTICS PLC-ADR (AKTX)
US00972G2075 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.85M | 13.25M | 9.36M | 14.06M | 5.73M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 496.00K | 570.00K | 2.26M | 520.00K | 710.00K | |||
| Total Current Assets | 4.34M | 13.81M | 11.63M | 14.58M | 6.44M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Intangibles | 14.00K | 20.00K | 20.00K | 30.00K | 30.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 14.00K | 20.00K | 20.00K | 20.00K | 40.00K | |||
| TOTAL ASSETS | 4.36M | 13.83M | 11.65M | 14.60M | 6.48M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.57M | 3.15M | 3.18M | 1.84M | 4.23M | |||
| Accounts Payable | 1.67M | 950.00K | 1.79M | 3.38M | 1.23M | |||
| Other Current Liabilities | 1.35M | 7.95M | 1.12M | 0.00 | 1.01M | |||
| Total Current Liabilities | 4.58M | 12.04M | 6.09M | 5.22M | 6.47M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 4.58M | 12.04M | 6.09M | 5.22M | 6.47M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -175.27M | -165.26M | -147.51M | -130.09M | -165.20M | |||
| Additional Paid In Capital | 174.75M | 167.08M | 153.13M | 139.73M | 133.57M | |||
| Common Shares | 1.32M | 740.00K | 480.00K | 380.00K | 31.99M | |||
| Other Shareholders' Equity | -1.04M | -770.00K | -540.00K | -650.00K | -350.00K | |||
| Shares Outstanding | 10.71M | 6.03M | 3.85M | 3.11M | 1.82M | |||
| Tangible Book Value per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Shareholders' Equity | -229.00K | 1.79M | 5.55M | 9.38M | 10.00K | |||
| TOTAL LIABILITIES AND EQUITY | 4.36M | 13.83M | 11.65M | 14.60M | 6.48M | |||
| Statistics | ||||||||
| Current Ratio | 0.95 | 1.15 | 1.91 | 2.79 | 1.00 | |||
| Return On Assets (ROA) | -229.80% | -128.34% | -149.53% | -116.99% | -260.03% | |||
| Return On Equity (ROE) | N/A | -991.62% | -313.87% | -182.09% | -168500.00% | |||
All data in USD